Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Negative effect of treatment with mGluR5 negative allosteric modulator AFQ056 on blood biomarkers in young individuals with Fragile X syndrome.
Journal: SAGE open medicine
Published: April 30, 2024
Cerliponase Alfa for the Treatment of Atypical Phenotypes of CLN2 Disease: A Retrospective Case Series.
Journal: Journal of child neurology
Published: December 28, 2020
Sleep disturbance in pediatric intracranial hypertension.
Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
Published: March 27, 2020
Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US Clinics.
Journal: Pediatric neurology
Published: December 31, 2019
Neurologic Consequences of Preterm Birth.
Journal: Current neurology and neuroscience reports
Published: June 17, 2018
Neuronal Ceroid Lipofuscinosis and Associated Sleep Abnormalities.
Journal: Pediatric neurology
Published: September 03, 2015
Showing 1-7 of 7
Last Updated: 09/26/2026